New Mexico 2024 Regular Session

New Mexico Senate Bill SB35

Caption

Medication For Juveniles In Treatment Pgms.

Impact

If enacted, SB35 will have a significant impact on state laws related to health and substance abuse treatment, particularly in the way that facilities manage care for minors. Starting in fiscal year 2026, any treatment facility that fails to comply with the requirement to provide MAT will be ineligible for Medicaid reimbursement for services provided to minors. This aspect of the bill aims to ensure that treatment facilities actively incorporate MAT into their programs, thus improving recovery outcomes for their young patients.

Summary

Senate Bill 35 aims to enhance the treatment of minors suffering from substance use disorders by mandating that all inpatient and outpatient substance abuse treatment facilities operating under state funding must provide medication-assisted treatment (MAT) without restrictions. This legislative push reflects a growing recognition of the necessity for comprehensive addiction treatment for young individuals, as the opioid crisis and other substance use issues have disproportionately affected this vulnerable demographic. The bill outlines a framework that precludes facilities from imposing policies that limit access to these life-saving treatments, thereby aligning treatment practices with evidence-based protocols.

Contention

The introduction of SB35 has sparked discussions regarding the appropriateness and implications of medication-assisted treatment for minors. Supporters argue that the bill is a critical step toward addressing addiction in youth and that MAT can be an effective intervention when properly administered. However, opponents may raise concerns about the potential stigma associated with MAT or question the adequacy of training for staff in treating minors with such methods. The bill’s requirement for reporting on MAT availability will also foster accountability and transparency but may meet with criticism regarding its implementation and bureaucratic implications.

Companion Bills

No companion bills found.

Previously Filed As

NM HB152

Medically Assisted Treatment For Juveniles

NM HB4585

INS CD-SUBSTANCE USE TREATMENT

NM AB1676

Mental health services: assisted outpatient treatment: involuntary medication.

NM HB4070

Relating to health care; and prescribing an effective date.

NM SB0065

Medication Assisted Treatment Amendments

NM HSB153

A bill for an act relating to services and support for youth, including treatment, physical assessments, and behavioral health evaluations; exemptions from children's residential facility certification; the director of juvenile court services and chief juvenile court officers; and suspension of Hawki eligibility for public institution inmates.(See HF 833, HF 984.)

NM SSB1120

A bill for an act relating to services and support for youth, including treatment, physical assessments, and behavioral health evaluations; exemptions from children's residential facility certification; the director of juvenile court services and chief juvenile court officers; and suspension of Hawki eligibility for public institution inmates.(See SF 474.)

NM SB726

Relating to medication-assisted treatment programs

NM HM58

Study Psilocybin-based Medication Treatment

NM HB179

Drug and alcohol treatment; require 30-day minimum in-patient treatment.

Similar Bills

WI AB925

Revising various provisions of the statutes for the purpose of making corrections and reconciling conflicts (Correction Bill).

WI SB904

Revising various provisions of the statutes for the purpose of making corrections and reconciling conflicts (Correction Bill).

US HB238

Residential Substance Use Disorder Treatment Act of 2023 This bill revises and reauthorizes through FY2027 grants for residential substance use disorder treatment programs at state and local correctional and detention facilities. Among the revisions, the bill replaces statutory references to substance abuse with substance use disorder, specifies that the term residential substance use disorder treatment program includes a medication-assisted treatment program, requires the chief medical officer or other staff overseeing a program to complete training on the science of addiction and the latest research and clinical guidance on treating substance use disorders in criminal justice settings, and allows people who are awaiting trial or in pretrial detention to participate in the programs.

NM HB152

Medically Assisted Treatment For Juveniles

NH HB751

Requiring licensure of outpatient substance use disorder treatment facilities and relative to complaint investigation of treatment facilities by the department of health and human services office of the ombudsman and making an appropriation therefor.

PA SB691

Establishing the Nonnarcotic Medication Substance Use Disorder Treatment Program; in organization and jurisdiction of courts of common pleas, providing for court assessments for substance use disorder treatment; in other criminal provisions, further providing for supervisory relationship to offenders; and, in Pennsylvania Board of Probation and Parole, further providing for supervisory relationship to offenders.

MA H2227

Replacing archaic and stigmatizing language for substance use

MO SB218

Modifies provisions relating to court operations